Evidence map›Paper›PMID 29385740›Full record

ArticleChildren (Basel, Switzerland)2018

Effects of Combining Medication and Pivotal Response Treatment on Aberrant Behavior in Children with Autism Spectrum Disorder.

Mohammad Rezaei, AliReza Moradi, Mehdi Tehrani-Doost, HamidReza Hassanabadi, Reza Khosroabadi

Open access · goldAbstract read
In one paragraph

Article in Children (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mohammad RezaeiInstitute for Cognitive Science Studies (ICSS), 16516-56717 Tehran, Iran. mohammad.rezaei@umsha.ac.ir.
AliReza MoradiInstitute for Cognitive Science Studies (ICSS), 16516-56717 Tehran, Iran. moradi@khu.ac.ir.
Mehdi Tehrani-DoostInstitute for Cognitive Science Studies (ICSS), 16516-56717 Tehran, Iran. tehranid@sina.tums.ac.ir.
HamidReza HassanabadiDepartment of Educational Psychology, Kharazmi University, 37551-31979 Tehran, Iran. hasanabadi@khu.ac.ir.
Reza KhosroabadiInstitute for Cognitive and Brain Sciences, Shahid Beheshti University GC, 19839-69411 Tehran, Iran. r_khosroabadi@sbu.ac.ir.
Institute for Cognitive Science Studies · IRKharazmi University · IRShahid Beheshti University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autism spectrum disorderbehavioral therapymedication

Identifiers

PMID29385740
PMCPMC5835988
OpenAlexW2788740997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.